PremiumThe FlyCo-Diagnostics submits FDA 510(k) application for Co-Dx PCR Pro platform Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro Co-Diagnostics price target lowered to $2 from $2.50 at H.C. Wainwright PremiumThe FlyCo-Diagnostics price target lowered to $2.50 from $3 at H.C. Wainwright Co-Diagnostics reports cash, equivalents of $58.5M as of December 31, 2023 Co-Diagnostics (CODX) Q4 Earnings Cheat Sheet PremiumThe FlyCo-Diagnostics awarded additional grant for tuberculosis test Co-Diagnostics appoints Ivory Chang as Chief Regulatory Affairs Officer Co-Diagnostics price target lowered to $2 from $3 at H.C. Wainwright